1. Home
  2. POAI vs FOXO Comparison

POAI vs FOXO Comparison

Compare POAI & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • FOXO
  • Stock Information
  • Founded
  • POAI 2002
  • FOXO 2019
  • Country
  • POAI United States
  • FOXO United States
  • Employees
  • POAI N/A
  • FOXO N/A
  • Industry
  • POAI Industrial Specialties
  • FOXO Retail: Computer Software & Peripheral Equipment
  • Sector
  • POAI Health Care
  • FOXO Technology
  • Exchange
  • POAI Nasdaq
  • FOXO Nasdaq
  • Market Cap
  • POAI 9.7M
  • FOXO 8.0M
  • IPO Year
  • POAI N/A
  • FOXO N/A
  • Fundamental
  • Price
  • POAI $1.46
  • FOXO $0.22
  • Analyst Decision
  • POAI Hold
  • FOXO
  • Analyst Count
  • POAI 1
  • FOXO 0
  • Target Price
  • POAI N/A
  • FOXO N/A
  • AVG Volume (30 Days)
  • POAI 2.8M
  • FOXO 13.4M
  • Earning Date
  • POAI 03-27-2025
  • FOXO 11-19-2024
  • Dividend Yield
  • POAI N/A
  • FOXO N/A
  • EPS Growth
  • POAI N/A
  • FOXO N/A
  • EPS
  • POAI N/A
  • FOXO N/A
  • Revenue
  • POAI $1,484,223.00
  • FOXO $1,341,000.00
  • Revenue This Year
  • POAI N/A
  • FOXO N/A
  • Revenue Next Year
  • POAI $569.48
  • FOXO N/A
  • P/E Ratio
  • POAI N/A
  • FOXO N/A
  • Revenue Growth
  • POAI N/A
  • FOXO 196.03
  • 52 Week Low
  • POAI $0.55
  • FOXO $0.13
  • 52 Week High
  • POAI $3.76
  • FOXO $1.30
  • Technical
  • Relative Strength Index (RSI)
  • POAI 59.80
  • FOXO 41.75
  • Support Level
  • POAI $1.36
  • FOXO $0.22
  • Resistance Level
  • POAI $1.58
  • FOXO $0.27
  • Average True Range (ATR)
  • POAI 0.21
  • FOXO 0.03
  • MACD
  • POAI -0.01
  • FOXO 0.00
  • Stochastic Oscillator
  • POAI 30.58
  • FOXO 7.30

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

Share on Social Networks: